- Home
- ENSC vs CHNR Comparison
ENSC vs CHNR Comparison
Compare ENSC & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- CHNR
- Stock Information
- Founded
- ENSC 2003
- CHNR N/A
- Country
- ENSC United States
- CHNR China
- Employees
- ENSC N/A
- CHNR N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- ENSC Health Care
- CHNR Basic Materials
- Exchange
- ENSC Nasdaq
- CHNR Nasdaq
- Market Cap
- ENSC 5.5M
- CHNR 4.6M
- IPO Year
- ENSC N/A
- CHNR 1995
- Fundamental
- Price
- ENSC $2.13
- CHNR $3.93
- Analyst Decision
- ENSC
- CHNR
- Analyst Count
- ENSC 0
- CHNR 0
- Target Price
- ENSC N/A
- CHNR N/A
- AVG Volume (30 Days)
- ENSC 84.7K
- CHNR 35.8K
- Earning Date
- ENSC 08-13-2025
- CHNR 05-15-2025
- Dividend Yield
- ENSC N/A
- CHNR N/A
- EPS Growth
- ENSC N/A
- CHNR N/A
- EPS
- ENSC N/A
- CHNR N/A
- Revenue
- ENSC $6,224,081.00
- CHNR N/A
- Revenue This Year
- ENSC N/A
- CHNR N/A
- Revenue Next Year
- ENSC $1,381.48
- CHNR N/A
- P/E Ratio
- ENSC N/A
- CHNR N/A
- Revenue Growth
- ENSC 256.35
- CHNR N/A
- 52 Week Low
- ENSC $1.62
- CHNR $3.35
- 52 Week High
- ENSC $14.67
- CHNR $9.04
- Technical
- Relative Strength Index (RSI)
- ENSC 45.62
- CHNR 51.28
- Support Level
- ENSC $1.97
- CHNR $3.61
- Resistance Level
- ENSC $2.40
- CHNR $4.15
- Average True Range (ATR)
- ENSC 0.17
- CHNR 0.24
- MACD
- ENSC -0.00
- CHNR 0.04
- Stochastic Oscillator
- ENSC 37.21
- CHNR 81.94
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.